The Company plans to manufacture, market and devel
Post# of 1422
The Company plans to manufacture, market and develop several new medical devices. Over the next 12 months, the company will seek strategic partners in equity finance, manufacturing and distribution to achieve these objectives.
The Company will not restructure again or propose any further reverse splits now or in the future. The Company believes it has more than adequate cash resources to see operations through the next 12 months.
Chronic back pain treatment in the United States alone is estimated to cost nearly $100 billion dollars annually. Utilizing recent Bureau of Labor Statistics data an estimate for the potential U.S. market for the MPDD is $2 billion and an additional $2.5 billion
globally, for a total potential market of $4.5 billion.
The Company projects that within 6 months of market launch, sales have the potential to exceed 2000 units per month worldwide and generating $10 million dollars per month.
Source - Read More: http://investorshangout.com/board/87206/EP-Gl...z2WglbUGcU
(0)
(0)